Roles for host and tumor angiotensin II type 1 receptor in tumor growth and tumor-associated angiogenesis

Laboratory Investigation

Volumn 87, Issue 2, 2007, Pages 189-198

  Imai, Nozomi ^a   Hashimoto, Tatsuo ^a   Kihara, Minoru ^a   Yoshida, Shin Ichiro ^a   Kawana, Ichiro ^a   Yazawa, Takuya ^a   Kitamura, Hitoshi ^a   Umemura, Satoshi ^a  

^a YOKOHAMA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Angiogenesis; Angiotensin II; AT1 receptor; Tumor growth; VEGF

Indexed keywords

ANGIOPOIETIN 1; ANGIOPOIETIN 2; ANGIOTENSIN 1 RECEPTOR; CANDESARTAN; CANDESARTAN HEXETIL; EPIDERMAL GROWTH FACTOR; MESSENGER RNA; VASCULOTROPIN A; VASCULOTROPIN RECEPTOR 2;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CANCER GROWTH; CARCINOMA CELL; CONTROLLED STUDY; HOST CELL; IN VITRO STUDY; LUNG CARCINOMA; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR GROWTH;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ANALYSIS OF VARIANCE; ANIMALS; BENZIMIDAZOLES; BIPHENYL COMPOUNDS; BLOTTING, WESTERN; CARCINOMA, LEWIS LUNG; ENZYME-LINKED IMMUNOSORBENT ASSAY; IMMUNOHISTOCHEMISTRY; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NEOVASCULARIZATION, PATHOLOGIC; RADIOIMMUNOASSAY; RENIN-ANGIOTENSIN SYSTEM; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; TETRAZOLES; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 33847326965     PISSN: 00236837     EISSN: 15300307     Source Type: Journal    
DOI: 10.1038/labinvest.3700504     Document Type: Article

References (44)

1. Brunner HR, Laragh JH, Baer L, et al. Essential hypertension: renin and aldosterone, heart attack and stroke. N Engl J Med 1972;286:441-449.
2. Kim S, Iwao H. Molecular and cellular mechanisms of angiotensin II-mediated cardiovascular and renal diseases. Pharmacol Rev 2000;52:11-34.
3. Timmermans PB, Wong PC, Chiu AT, et al. Angiotensin II receptors and angiotensin II receptor antagonists. Pharmacol Rev 1993;45:205-251.
4. Burnier M. Angiotensin II type 1 receptor blockers. Circulation 2001;103:904-912.
5. Viswanathan M, Stromberg C, Seltzer A, et al. Balloon angioplasty enhances the expression of angiotensin II AT1 receptors in neointima of rat aorta. J Clin Invest 1992;90:1707-1712.
6. Harada K, Komuro I, Sugaya T, et al. Vascular injury causes neointimal formation in angiotensin II type 1a receptor knockout mice. Circ Res 1999;84:179-185.
7. Rossig L, Dimmeler S, Zeiher AM. Apoptosis in the vascular wall and atheroscrelosis. Basic Res Cardiol 2001;96:11-22.
8. Wesselman JP, De Mey JG. Angiotensin and cytoskeletal proteins: role in vascular remodeling. Curr Hypertens Rep 2002;4:63-70.
9. Inokuchi Y, Morohashi T, Kawana I, et al. Amelioration of 2, 4, 6-trinitrobenzene sulphonic acid induced colitis in angiotensinogen gene knockout mice. Gut 2005;54:349-356.
10. Tamarat R, Silvestre JS, Duriez M, et al. Angiotensin II angiogenic effect in vivo involves vascular endothelial growth factor-and inflammation-related pathways. Lab Invest 2002;82:747-756.
11. Sasaki K, Murohara T, Ikeda H, et al. Evidence for the importance of angiotensin II type 1 receptor in ischemia-induced angiogenesis. J Clin Invest 2002;109:603-611.
12. Bell L, Madri JA. Influence of the angiotensin system on endothelial and smooth muscle cell migration. Am J Pathol 1990;137:7-12.
13. Paquet J, Baudouin-Legros M, Carbini L, et al. Angiotensin II-induced proliferation of aortic myocytes in spontaneously hypertensive rats. J Hypertens 1990;8:565-572.
14. Nadal JA, Scicli GM, Carbini LA, et al. Angiotensin II and retinal pericytes migration. Biochem Biophys Res Commun 1999;266:382-385.
15. Otani A, Takagi H, Oh H, et al. Angiotensin II-stimulated vascular endothelial growth factor expression in bovine retinal pericytes. Invest Ophthalmol Vis Sci 2000;41:1192-1199.
16. Andrade SP, Cardoso CC, Machado RD, et al. Angiotensin-II-induced angiogenesis in sponge implants in mice. Int J Microcirc Clin Exp 1996;16:302-307.
17. Hu DE, Hiley CR, Fan TP, et al. Comparative studies of the angiogenic activity of vasoactive intestinal peptide, endothelins-1 and -3 and angiotensin II in a rat sponge model. Br J Pharmacol 1996;117:545-551.
18. Deshayes F, Nahmias C. Angiotensin receptors: a new role in cancer? Trends Endoclinol Metab 2005;16:293-299.
19. Lever AF, Hole DJ, Gillis CR, et al. Do inhibitors of angiotensin-I-converting enzyme protect against risk of cancer? Lancet 1998;352:179-184.
20. Yoshiji H, Kuriyama S, Kawata M, et al. The angiotensin-I- converting enzyme inhibitor Perindopril suppresses tumor growth and angiogenesis: possible role of the vascular endothelial growth factor. Clin Cancer Res 2001;7:1073-1078.
21. Yoshiji H, Yoshii J, Ikenaka Y, et al. Suppression of the renin-angiotensin system attenuates vascular endothelial growth factor-mediated tumor development and angiogenesis in murine hepatocellular carcinoma cell. Int J Oncol 2002;20:1227-1231.
22. Yasumatsu R, Nakashima T, Masuda M, et al. Effects of the angiotensin-I-converting enzyme inhibitor perindopril on tumor growth and angiogenesis in head and neck squamous cell carcinoma cells. J Cancer Res Clin Oncol 2004;130:567-573.
23. Fabre JE, Rivard A, Magner M, et al. Tissue inhibition of angiotensin-converting enzyme activity stimulates angiogenesis in vivo. Circulation 1999;99:3043-3049.
24. Takeshita S, Tomiyama H, Yokoyama N, et al. Angiotensin-converting enzyme inhibition improves defective angiogenesis in the ischemic limb of spontaneously hypertensive rats. Cardiovasc Res 2001;52:314-320.
25. Egami K, Murohara T, Shimada T, et al. Role of host angiotensin II type 1 receptor in tumor angiogenesis and growth. J Clin Invest 2003;112:67-75.
26. Fujita M, Hayashi I, Yamashina S, et al. Angiotensin type 1a receptor signaling-dependent induction of vascular endothelial growth factor in stroma is relevant to tumor-associated angiogenesis and tumor growth. Carcinogenesis 2005;26:271-279.
27. Uemura H, Ishiguro H, Nagashima Y, et al. Antiproliferative activity of angiotensin II receptor blocker through cross-talk between stromal and epithelial prostate cancer cells. Mol Cancer Ther 2005;4:1699-1709.
28. Miyajima A, Kosaka T, Asano T, et al. Angiotensin II type I antagonist prevents pulmonary metastasis of murine renal cancer by inhibiting tumor angiogenesis. Cancer Res 2002;62:4176-4179.
29. Fujimoto Y, Sasaki T, Tsuchida A, et al. Angiotensin II type 1 receptor expression in human pancreatic cancer and growth inhibition by angiotensin II type 1 receptor antagonist. FEBS Lett 2001;495:197-200.
30. Shibouta Y, Inada Y, Ojima M, et al. Pharmacological profile of a highly potent and long-acting angiotensin II receptor antagonist, 2-ethoxy-1-{[2′-(1H-tetrazol-5-yl) biphenyl-4-yl] methyl}-1H benzimidazole-7-carboxylic acid (CV11974), and its prodrug, (+/-)-1- (cyclohexyloxycarbonyloxy)-ethyl 2-ethoxy-1-{[2′-(1H-tetrazol-5-yl) biphenyl-4-yl] methyl}-1H-benzimidazole-7-carboxylate (TCV-116). J Pharmacol Exp Ther 1993;266:114-120.
31. Bertram JS, Janik P. Establishment of a cloned line of lewis lung carcinoma cells adapted to cell culture. Cancer Lett 1980;11:63-73.
32. Hashimoto T, Kihara M, Sato K, et al. Heparin recovers AT1 receptor and its intracellular signal transduction in cultured vascular smooth muscle cells. FEBS Lett 2005;579:281-284.
33. Sugaya T, Nishimatsu S, Tanimoto K, et al. Angiotensin II type 1a receptor-deficient mice with hypotension and hyperreninemia. J Biol Chem 1995;270:18719-18722.
34. Minakuchi Y, Takeshita F, Kosaka N, et al. Atelocollagen-mediated synthetic small interfering RNA delivery for effective gene silencing in vitro and in vivo. Nucleic Acids Res 2004;32:e109.
35. Ishii H, Yazawa T, Sato H, et al. Enhancement of pleural dissemination and lymph node metastasis of intrathoracic lung cancer cells by vascular endothelial growth factors (VEGFs). Lung Cancer 2004;45:325-337.
36. Ishida J, Asada S, Daitoku H, et al. Expression and characterization of mouse angiotensin II type 1a receptor tagging hemagglutinin epitope in cultured cells. Int J Mol Med 1999;3:263-270.
37. Kihara M, Sato K, Hashimoto T, et al. Expression of endothelial nitric oxide synthase is suppressed in the renal vasculature of angiotensinogen-gene knockout mice. Cell Tissue Res 2006;323:313-320.
38. Sato K, Kihara M, Hashimoto T, et al. Alteration in renal endothelial nitric oxide synthase expression by salt diet in angiotensin type-1a receptor gene knockout mice. J Am Soc Nephrol 2004;15:1756-1763.
39. Hashimoto T, Kihara M, Ishida J, et al. Apelin stimulates myosin light chain phosphorylation in vascular smooth muscle cells. Arterioscler Thromb Vasc Biol 2006;26:1267-1272.
40. Ziada AM, Hudlicka O, Tyler KR, et al. The effect of long-term vasodilation on capillary growth and performance in rabbit heart and skeletal muscle. Cardiovasc Res 1984;18:724-732.
41. Zhu Z, Zhang SH, Wagner C, et al. Angiotensin AT1b receptor mediated calcium signaling in vascular smooth muscle cells of AT1a receptor-deficient mice. Hypertension 1998;31:1171-1177.
42. Kim KJ, Li B, Winer J, et al. Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumor growth in vivo. Nature 1993;362:841-844.
43. Kang YS, Park YG, Kim BK, et al. Angiotensin II stimulates the synthesis of vascular endothelial growth factor through the p38 mitogen activated protein kinase pathway in cultured mouse podocytes. J Mol Endocrinol 2006;36:377-388.
44. Suganuma T, Ino K, Shibata K, et al. Functional expression of the angiotensin II type 1 receptor in human ovarian carcinoma cells and its blockade therapy resulting in suppression of tumor invasion, angiogenesis, and peritoneal dissemination. Clin Cancer Res 2005;11:2686-2694.